Sensyne Health PLC
LSE:SENS
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
UK |
Sensyne Health PLC
LSE:SENS
|
576.8k GBP | 0.2 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
33.9B USD | 69.6 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 38.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 111.6 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.8B AUD | 116.1 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 14.4 | ||
US |
Doximity Inc
NYSE:DOCS
|
5.3B USD | 26.5 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
4.7B USD | -117 | ||
SE |
Sectra AB
STO:SECT B
|
45.7B SEK | -71 | ||
US |
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 4 233.4 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.7B USD | -92.6 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.